Nursing Process Focus: Patients Receiving Chlorpromazine (Thorazine)
|
|
- Constance Sparks
- 6 years ago
- Views:
Transcription
1 Nursing Process Focus: Patients Receiving Chlorpromazine (Thorazine) Potential Nursing Diagnoses Ineffective Therapeutic Regimen Management Risk for Activity Intolerance, related to side effect of drug Deficient Knowledge, related to drug action and side effects Constipation, related to decreased intestinal motility Risk for Injury, related to drug effects Planning: Patient Goals and Expected Outcomes Assessment Prior to administration: Obtain complete health history, especially of mental illness, respiratory, gastrointestinal, genitourinary disorders, alcohol and illegal drug use. Include blood studies: electrolytes, CBC, BUN, creatinine, HCG levels if indicated, and drug screens (for use of illegal drugs.) Obtain patient s drug history to determine possible drug interactions and allergies. The patient will: Experience relief of positive symptoms of schizophrenia, and relief of manic symptoms in patients with schizo-affective disorder. Demonstrate an understanding of the drug s action by accurately describing drug side effects and precautions, and measures to take to decrease any side effects. Adhere strictly to the recommended treatment. Abstain from alcohol and illegal drug use. Immediately report any occurrence of any adverse reactions. Implementation Interventions and (Rationales) *Monitor for EPS and NMS. Medications may be available to treat EPS. (Presence of EPS may be sufficient reason for patient to discontinue chlorpromazine; NMS is lifethreatening and must be reported and treated immediately.) *Monitor for cheeking, hoarding or sharing medication. Observe patient closely for noncompliance. (If therapeutic results are not seen, patient may not be taking medication as ordered, even though he/she may appear to be taking it.) *Observe for side effects such as orthostatic hypotension, constipation, anorexia, GU problems, respiratory changes, visual disturbances. (These side effects are caused by the anticholinergic effects of chlorpromazine.) Patient Education/Discharge Planning Teach patient and family to: Recognize tardive dyskinesia, dystonia, akathesia, pseudoparkinsonism. Recognize and seek treatment immediately for elevated temperature, unstable blood pressure, profuse sweating, dyspnea, muscle rigidity, and incontinence. Teach patient/family: Importance of taking medication exactly as ordered, and not sharing it with anyone. How to check to be sure patient has swallowed medication. *Inform patient that impotence, gynecomastia, amenorrhea or enuresis may occur. Instruct patient: To change position and arise slowly. Do not to drive a car until he/she is stabilized on chlorpromazine and sedating effects are known.
2 *Monitor for use of medication. (Medication must be gradually withdrawn over a 2-3 week time, or patient may experience nausea/vomiting, dizziness, tremors, or dyskinesia.) *Monitor patient for respiratory depression, laryngospasm, dyspnea. *Monitor for caffeine use. (Caffeine will cause a decreased therapeutic response of chlorpromazine.) *Monitor patient s environment. (Chlorpromazine may cause patient to perceive brownish discoloration of objects or photophobia. Chlorpromazine may also interfere with the body s ability to regulate body temperature.) *Observe for evidence of alcohol/illegal drug use. (The patient may use alcohol/illegal drugs as means as coping with symptoms of psychosis.) To report vision changes. To comply with required laboratory tests as ordered, e.g. Thorazine levels, electrolytes, CBC, BUN, and creatinine. To increase roughage in diet, increase fluids, and increase exercise to decrease or avoid constipation. Instruct patient: *To continue taking the medication as ordered, even if no therapeutic benefits are felt. *That it may take 6 weeks-6 months for full therapeutic benefits. *Instruct patient that if any respiratory symptoms occur, their health care provider must be notified. *Instruct patient to avoid caffeine in common products containing caffeine, including: coffee, tea, carbonated beverages, and chocolate. Instruct patient to: *Wear dark glasses to avoid discomfort from photophobia. *Avoid temperature extremes. *Instruct the patient to refrain from alcohol/illegal drug use. Evaluation of Outcome Criteria Evaluate the effectiveness of drug therapy by confirming that patient goals and expected outcomes have been met (see Planning ).
3 Assessment Prior to administration: Assess for hallucinations and the level of consciousness both initially and throughout drug therapy. Obtain a complete health and psychological history especially in regards to cardiovascular and neurological disorders. Include blood studies such as CBC, liver enzymes, and electrolytes and obtain an EKG. Obtain the patient s drug history to determine possible drug interactions and allergies. Nursing Process Focus: Patients Receiving Haloperidol (Haldol) Potential Nursing Diagnoses Anxiety, related to disease process Risk for Injury, related to drug effects Deficient Knowledge, related to drug action and side effects Ineffective Therapeutic Regimen Management Planning: Patient Goals and Expected Outcomes Patient will: Report decreased symptoms of psychosis. Demonstrate an understanding of the drug s action by accurately describing drug side effects and precautions, and measures to take to decrease any side effects. Immediately report side effects and adverse reactions. Adhere to a medication regimen. Implementation Interventions and (Rationales) *Monitor for EPS and NMS. Medications may be available to treat EPS. (Presence of EPS may be sufficient reason for patient to discontinue medication; NMS is lifethreatening and must be reported and treated immediately.) *Observe for seizures. Use with caution in patients with pre-existing seizure disorders. (Haloperidol decreases seizure threshold.) *Observe for side effects such as severe drowsiness, dizziness, lethargy, headaches, blurred vision, skin rash, diaphoresis, nausea/vomiting, anorexia, diarrhea, and menstrual irregularities. *Monitor for anticholinergic side effects such as dry mouth, constipation, and urinary retention. Patient Education/Discharge Planning Teach patient and family: To recognize tardive dyskinesia, dystonia, akathesia, pseudoparkinsonism. To recognize and seek treatment immediately for elevated temperature, unstable blood pressure, profuse sweating, dyspnea, muscle rigidity, and incontinence. Teach patient/family: That seizures may occur. Safety precautions in case a seizure does occur. Instruct the patient: To report side effects. Do not drive or operate dangerous machinery when taking the medication. Teach patient and family: Measures to relieve symptoms such as sugarless hard candy or gum and frequent drinks of water for dry mouth; increased
4 *Monitor for adverse reactions, including hypotension (use of anti-psychotics causes lowering of blood pressure) OR hypertension (occurs with overdosage), EKG changes, leukopenia, jaundice, altered liver function tests. *Monitor patient s lab tests, observing for leukopenia. *Monitor for alcohol/illegal drug use. (Patients may decide to drink alcohol, so will stop taking the haloperidol. These substances will have an additive CNS depressant effect.) *Discourage caffeine use. *Monitor for cardiovascular changes, including hypotension, tachycardia, and EKG changes. (Haloperidol has fewer cardiotoxic effects than other antipsychotics, and may be preferred for patient with existing CV problems.) *Use with caution in elderly patients. (Older patient may have unusual adverse reactions. They need lower doses and a more gradual dosage increase. Elderly women are at greater risk for developing tardive dyskinesia.) *Encourage smoking cessation. (Heavy smoking causes decreased metabolism of haloperidol, and therefore decreased efficacy.) fluids, fruits and vegetables for constipation; To notify the health care provider if urinary retention occurs. Inform patient/family: That routine lab studies (haloperidol levels, CBC, liver function tests, etc.) and other exams must be done. To change position slowly, in case hypotension occurs, to prevent injury. *Caution the patient to refrain from taking illegal drugs and alcohol. *Caution the patient that combining caffeine with haloperidol will decrease the effectiveness of the drug and likely increase anxiety. Teach patient: That dizziness and falls, especially upon sudden position changes, may indicate CV changes. Safety measures. To have regular medical follow-up. Teach patient/family: To observe for unusual reactions such as confusion, depression and hallucinations and to report them immediately. To observe for symptoms of tardive dyskinesia and report them as soon as they occur. *Advise patient to decrease or discontinue smoking; refer to smoking cessation classes if desired. Evaluation of Outcome Criteria Evaluate the effectiveness of drug therapy by confirming that patient goals and expected outcomes have been met (see Planning ).
5 Assessment Prior to administration: Assess for hallucinations, mental status, dementia, bipolar disorder (initially and throughout therapy). Obtain complete health history, especially psychological, neurologic and blood diseases: including blood studies: CBC, WBC with differential, electrolytes, BUN, creatinine, liver enzymes. Obtain patient s drug history to determine possible drug interactions and allergies. Nursing Process Focus: Patients Receiving Clozapine (Clozaril) Potential Nursing Diagnoses Anxiety, related to disease process Risk for Injury, related to effects of drug Noncompliance, related to side effects of drug Disturbed Sleep Pattern, related to drug effect Deficient Knowledge, related to drug action and side effects Planning: Patient Goals and Expected Outcomes The patient will: Report a reduction of psychotic symptoms, including delusions, paranoia, irrational behavior. Demonstrate an understanding of the drug s action by accurately describing drug side effects and precautions, and measures to take to decrease any side effects. Adhere to recommended therapy, including medications, psychotherapy, health care provider and lab appointments. Refrain from alcohol, caffeine, smoking, other CNS depressants. Implementation Interventions and (Rationales) *Monitor RBC and WBC counts. If WBC levels drop < 3500, medication will need to be stopped immediately. (Patient may be developing agranulocytosis, which could be life-threatening.) *Monitor for hematologic side effects. (Neutropenia, leukopenia, agranulocytosis, thrombocytopenia may occur, secondary to possible bone marrow suppression caused by clozapine.) *Observe for side effects such as drowsiness, sedation, dizziness, depression, anxiety, tachycardia, hypotension, nausea/vomiting, excessive salivation, urinary frequency or urgency, incontinence, weight gain, muscle pain or weakness, rash, fever. *Monitor for anticholinergic side effects: mouth dryness, constipation, urinary retention. Urinary retention may be corrected only by use of an indwelling catheter. Patient Education and Discharge Planning *Advise patient of the importance of having weekly lab studies done. *Instruct patient to report immediately any sore throat, signs of infection, fatigue, bruising, without apparent cause. *Instruct patient to report side effects to the health care provider. Inform patient that: Mouth dryness and constipation can be decreased with sugarless gum or candy, increased fluids, frequent sips of water,
6 *Monitor for decrease of psychotic symptoms. Medication is working as it should if patient exhibits more normal thoughts and behaviors. (If patient continues to exhibit symptoms of psychosis, either he is not taking medications as ordered, he is taking an inadequate dose, or he is immune to it and it will need to be discontinued and another anti-psychotic begun.) *Monitor for alcohol use. (Alcohol used concurrently with clozapine will cause increased CNS depression. Patient may decide to stop taking clozapine because he wishes to use alcohol.) *Discourage caffeine use. (Use of caffeinecontaining substances will negate effects of clozapine.) *Encourage smoking cessation. (Heavy smoking may decrease blood levels of clozapine.) *Monitor elderly closely, and give lower doses. (They may be more sensitive to anticholinergic effects.) increased fruits and vegetables in diet. If urinary retention occurs, notify health care provider immediately to prevent complications. Teach patient/family to: Look for more normal behaviors (completing own ADLs, showing more interest in surroundings, more normal sleep patterns, etc.), to notice decrease or absence of symptoms of psychosis, including hallucinations, delusions, paranoia, etc. Contact health care provider if no decrease of symptoms occurs over a six week period. Instruct patient to: Refrain from alcohol use; refer to Alcoholics Anonymous or another support group if indicated. Take medication as ordered; do not stop medication and drink alcohol. *Inform patient of common caffeine-containing products, including coffee, tea, carbonated beverages, chocolate, etc. *Instruct patient to stop or decrease smoking; refer to smoking cessation programs if indicated. *Teach elderly patients ways to counteract anticholinergic effects of medication, while taking into account any other existing medical problems. Evaluation of Outcome Criteria Evaluate the effectiveness of drug therapy by confirming that patient goals and expected outcomes have been met (see Planning ).
Chapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses
Chapter 17 Psychoses Drugs for Psychoses Delusions Hallucinations Illusions Paranoia Upper Saddle River, New Jersey 07458 All rights reserved. Classifications of Psychoses Acute episode Chronic episode
More informationNursing Process Focus: Patients Receiving Levodopa (Larodopa)
Assessment Prior to administration: Obtain complete health history including allergies, drug history and possible drug interactions. Obtain baseline evaluation of severity of Parkinson s disease to determine
More informationInstruct patient and caregivers: Need for constant monitoring Potential complications of drug therapy
Assessment Prior to administration: Assess patient for chest pain, dysrhythmias, and vital signs (initially and throughout therapy) Obtain complete medical history, including allergies, especially heart
More informationNursing Process Focus: Patients Receiving Salmeterol (Serevent)
Prior to administration: Assess for presence/history of chronic asthma, exercise induced asthma, acute asthma attacks, and acute upper airway obstruction. Assess respiratory rate and lung sounds, pulse
More informationNURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet)
NURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet) ASSESSMENT Prior to administration: Obtain complete health history including allergies, drug history, and possible drug interactions.
More informationANTIPSYCHOTICS AGENTS CONVENTIONAL
ANTIPSYCHOTICS AGENTS CONVENTIONAL Documentation A. FDA approved indications 1. Psychotic Disorder (Haloperidol, Thiothixene) 2. Schizophrenia 3. Bipolar Disorder, Manic (Chlorpromazine) 4. Severe Behavioral
More informationPatient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension
Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension Read this Patient Information before you start taking VERSACLOZ and each time you get a refill. There may be new information. This
More informationHave you already tried different drugs for your schizophrenia? Here s another option you and your doctor may want to consider.
Have you already tried different drugs for your schizophrenia? Here s another option you and your doctor may want to consider. 1 Benefits of Clozapine Clozapine may work when other medications don t. Doctors
More informationIntroductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs
Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Dopaminergic Drugs: Actions Symptoms of parkinsonism are caused by depletion of dopamine in CNS Amantadine: makes more of dopamine available
More informationNursing Process Focus: Patients Receiving Bethanechol (Urecholine)
Assessment Prior to administration: Assess for urinary retention, urinary patterns (initially and throughout therapy). Obtain complete health history; including allergies, drug history and possible drug
More informationDrugs for Emotional and Mood Disorders Chapter 16
Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,
More informationChapter 20. Media Directory. Amyotrophic Lateral Sclerosis. Alzheimer s Disease. Huntington s Chorea. Multiple Sclerosis
Chapter 20 Drugs for Degenerative Diseases of the Nervous System Slide 18 Media Directory Levadopa Animation Upper Saddle River, New Jersey 07458 All rights reserved. Alzheimer s Disease Amyotrophic Lateral
More informationCOALINGA STATE HOSPITAL NURSING POLICY AND PROCEDURE MANUAL SECTION - Medications POLICY NUMBER: 510
COALINGA STATE HOSPITAL NURSING POLICY AND PROCEDURE MANUAL SECTION - Medications POLICY NUMBER: 510 Effective Date: August 31, 2006 SUBJECT: CARE OF THE INDIVIDUAL RECEIVING CLOZAPINE 1. GENERAL: Clozapine
More informationMedication Audit Checklist- Antipsychotics - Atypical
Medication Audit checklist Page 1 of 7 10-2018 Audit number: Client number: Ordering Provider: INDICATIONS 1) Disorders with psychotic symptoms (schizophrenia, schizoaffective disorder, manic disorders,
More information*Monitor for significant side effects, especially symptoms of neurological or cardiovascular events.
Assessment Prior to administration: Obtain complete health history including allergies, drug history, and possible drug reactions Assess reason for drug administration such as presence/history of anemia
More informationSymbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination)
Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination) Generic name: Olanzapine and fluoxetine combination Available strengths: 6 mg/25 mg, 6 mg/50 mg, 12 mg/25 mg, 12 mg/50 mg (Zyprexa/Prozac)
More informationNursing Process Focus: Patients Receiving Phenelzine (Nardil)
Assessment Prior to administration: Obtain complete health history including allergies, neurological, cardiac, renal, biliary, and mental disorders including blood studies: CBC, platelets and liver enzymes.
More informationTricyclic Antidespressants: Actions
Introductory Clinical Pharmacology Chapter 24 Antidepressant Drugs Tricyclic Antidespressants: Actions Increase sensitivity in postsynaptic alpha (α)-adrenergic, serotonin receptors Decrease sensitivity
More informationScottsdale Family Health
Please list pharmacy you would like us to use for your medications. Pharmacy Phone Number Fax Number Since your last visit: 1. Have you been diagnosed with any new medical conditions? Yes No If Yes (give
More informationOlanzapine generichealth tablets Olanzapine benzoate
CONSUMER MEDICINE INFORMATION Olanzapine generichealth tablets Olanzapine benzoate What is in this leaflet This leaflet is designed to provide you with answers to some common questions about this medicine.
More informationAntipsychotic Use in the Elderly
Antipsychotic Use in the Elderly Presented by: Fatima M. Ali, PharmD, RPh, BCPS Clinical Consultant Pharmacist MediSystem Pharmacy, Kingston Originally Prepared by: Nicole Tisi BScPhm, RPh ACPR Disclosure
More informationOLANZAPINE-SYNTHON Olanzapine benzoate
Olanzapine benzoate Consumer Medicine Information What is in this leaflet This leaflet is designed to provide you with answers to some common questions about this medicine. It does not contain all the
More informationObjectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia
Objectives Identify positive and negative symptoms used for diagnosis of schizophrenia Mohamed Sallout, Pharm D. Pharmacist Resident St. Luke s Magic Valley Regional Medical Center List medications used
More informationMonitor patient s ability to self-administer insulin. (To evaluate safe administration of drug.)
Nursing Process Focus: Patients Receiving Regular Insulin (Humulin, Novolin) Assessment Prior to administration: Assess any patient allergies. Older forms of insulin are made from beef and pork and may
More informationCare for patients with Neurological disorders
King Saud University College of Nursing Medical Surgical Department Application of Adult Health Nursing Skills ( NUR 317 ) Care for patients with Neurological disorders Outline; EEG Overview. Nursing Interventions;
More informationMEDICATION GUIDE. Quetiapine (kwe-tye-a-peen) Tablets USP
MEDICATION GUIDE Quetiapine (kwe-tye-a-peen) Tablets USP Read this Medication Guide before you start taking quetiapine tablets and each time you get a refill. There may be new information. This information
More informationMedication is just part of the management of these illnesses. Other therapies are also helpful; you may wish to discuss these with your prescriber.
Know Your Medicines Duloxetine The purpose of this leaflet is to give you some general information on duloxetine, and is intended as a guide only. This should be read in conjunction with the official patient
More informationCetirizine Proposed Core Safety Profile
Cetirizine Proposed Core Safety Profile Posology and method of administration Elderly subjects: data do not suggest that the dose needs to be reduced in elderly subjects provided that the renal function
More informationAmitriptyline, Nortriptyline or Imipramine
NHS Greater Glasgow And Clyde Pain Management Service Information for Adult Patients who are Prescribed Amitriptyline, Nortriptyline or Imipramine For the Treatment of Pain This information is not intended
More informationElements for a Public Summary
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Schizophrenia Schizophrenia is a mental illness with a number of symptoms, including confused or unclear thinking and speech,
More informationNausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules.
Nausicalm Cyclizine lactate 50 mg/ml solution for injection Presentation Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules. Uses Actions Cyclizine is a piperazine
More informationDOB: / / Please list the names and telephone numbers of the other physicians involved in your care: Name Specialty Phone Address Receive Report (Y/N)
Medical History: Patient: DOB: / / Please list the names and telephone numbers of the other physicians involved in your care: Name Specialty Phone Address Receive Report (Y/N) List the names of prescription
More informationHeadache Follow-up Visit Form
!1 Headache Follow-up Visit Form We will be unable to see you unless this form is completely filled out. We appreciate your thoroughness. Name DOB Age Today s Date Referring doctor: Primary doctor: Neurologist:
More informationThe licensed indications for the use of Clozapine are:- Treatment resistant schizophrenia.
1. Introduction Future Directions CIC will support the use of the antipsychotic Clozapine in all appropriate cases. The purpose of this procedure is to set out the standards for Clinicians, Pharmacists,
More informationWhat Team Members Other Than Prescribers Need To Know About Antipsychotics
What Team Members Other Than Prescribers Need To Know About Antipsychotics The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION Pr BACLOFEN Baclofen Tablets 10 mg and 20 mg This leaflet is part III of a three-part "Product Monograph" published when BACLOFEN was approved for sale in Canada and is designed
More informationCECILIA P MARGRET MD PhD MPH Child, Adolescent and Adult Psychiatry NE 24th ST Suite 104, Bellevue WA 98007, Phone / Fax: +1 (425)
IDENTIFYING INFORMATION PATIENT INFORMATION FORM Patient's Name: DOB: Ethnicity/race: Gender: Primary language if other than English: Address: Phone: Home/ Mobile/ Work Email: Occupation: Marital Status:
More informationMedical History Form
Medical History Form NAME DOB / / TODAY S DATE MEDICAL HISTORY What medical Conditions do you have? Select all that apply, or write in if not listed: Diabetes High Blood Pressure Thyroid Disorder Heart
More informationPERSONAL MEDICAL AND FAMILY HISTORY Please check applicable boxes.
Name: DOB: PERSONAL MEDICAL AND FAMILY HISTORY Please check applicable boxes. TOBACCO USE: Quit Date Cigarettes Packs/Day Number of years smoked Pipe/Cigar Smokeless Tobacco Electronic or E-cigarette Secondhand
More informationMedications and the I/DD Population
Medications and the I/DD Population A Supplemental Document to Session 4 in Webinar Series ADR Symptoms that Mimic Age Related/Associated Changes and Diseases Biological Changes Impaired senses Cardiovascular
More informationNursing Process Focus: Patients Receiving Dextran 40 (Gentran 40)
Assess for presence/history of hypovolemia, shock, venous thrombosis. Assess vital signs: Hypovolemic shock secondary to surgery, burns, hemorrhage, other serious condition PT and PTT abnormalities Venous
More informationAntidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych
Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.
More informationTREANA 5mg and 10mg Film-coated Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER TREANA 5mg and 10mg Film-coated Tablets OLANZAPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationJOHN MICHAEL ROACH, MD
GASTROENTEROLOGY JOHN MICHAEL ROACH, MD 520 N. 4 TH AVE. PASCO, WA 99301 Phone: (509) 546-8383 Name: Date of Birth: First Middle (full) Last m/d/yr Primary care provider: Referring physician: Local Pharmacy:
More informationNHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Pregabalin. For the Treatment of Pain
NHS Greater Glasgow And Clyde Pain Management Service Information for Adult Patients who are Prescribed Pregabalin For the Treatment of Pain This information is not intended to replace your doctor s advice.
More informationNCDPS Health Services Elissa Brody, CNM, BSN, RN Education Director June 2017
NCDPS Health Services Elissa Brody, CNM, BSN, RN Education Director June 2017 Disclosure NC Department of Public Safety Division of Adult Corrections/Prisons Health Services- Nursing Education NCNA Approved
More informationSTARTING PATIENTS ON. AA-CLOZAPINE is the only Canadian-made treatment indicated for the symptoms of treatment-resistant schizophrenia.
STARTING PATIENTS ON AA-CLOZAPINE is the only Canadian-made treatment indicated for the symptoms of treatment-resistant schizophrenia. Indication: AA-CLOZAPINE (clozapine) is indicated in the management
More informationUsing Gabapentin and Pregabalin for Chronic Pain
2014 Using Gabapentin and Pregabalin for Chronic Pain Medication name: Dosage: Using Gabapentin and Pregabalin for Chronic Pain How can these medications help me? These medications are often used for treating
More informationTOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE
trazodone TOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE Pharmacodynamics study of what a drug does to the body Studies show that trazodone selectively inhibits neuronal
More informationPATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE
SCHEDULING STATUS: S5 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: ZOXADON 0,5 mg: Each tablet contains 0,5 mg risperidone. ZOXADON 1 mg: Each tablet contains 1 mg risperidone. ZOXADON 2 mg: Each
More informationPatient Information. Marital Status (Single, Married, Life Partner, Divorced, Widowed) CHIEF COMPLAINT
Patient Information Name Date Home Address City State Zip Phone E-mail Address Cell Phone: Business Address City State Zip Phone Occupation Place of Birth Date of Birth Age Height Weight Soc. Sec. # Sex
More informationElements for a Public Summary. VI.2.1 Overview of disease epidemiology
VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Schizophrenia Schizophrenia is a mental disorder often characterized by abnormal social behaviour and failure to recognize what
More informationJoseph S. Weiner, MD, PC Patient History Form
Date: / / NAME: Last First M. I. Age: Sex: q F q M Birthdate: / / What specific questions or goals do you have for this appointment? Please list the names of other clinicians you have seen for this problem:
More informationAripiprazole Accord 5, 10, 15 and 30 mg film-coated tablets
Aripiprazole Accord 5, 10, 15 and 30 mg film-coated tablets EDUCATIONAL MATERIAL FOR THE PATIENTS AND THEIR CAREGIVERS Introduction Your doctor has diagnosed you with bipolar I disorder and prescribed
More informationQuestionnaire for Lipedema Patients
Questionnaire for Lipedema Patients Name Date of diagnosis Date Name of physician making diagnosis Do you also have lymphedema? What areas of the body are affected? Outside of thighs Inner thighs Knees
More informationHistory of Present Illness Please answer the following questions
Last Name First Name Date of Birth: / / What is the main reason for your visit today? Social Security Number: History of Present Illness Please answer the following questions Bladder Cancer Urinary Tract
More informationPROBABLE HEALTH CONSEQUENCES OF NOT TAKING THIS MEDICATION
University Health System PSYCHIATRIC SERVICES ANTIPSYCHOTICS Atypical Neuroleptics Risperdal (Risperidone ) Olanzapine (Zyprexa ) Quetiapine (Seroquel ) Course of Treatment: PURPOSE AND GENERAL INFORMATION
More informationPatient Name Date of Birth Page 1 of 6
2545 W. Hillcrest Dr. #205 Thousand Oaks, CA 91320 Admissions: 888.822.8938 Fax: 805.273.5246 Dear Medical Professional, This patient is seeking care to address eating disorder behaviors. For the patient
More informationLECTOPAM PRODUCT MONOGRAPH. bromazepam. 3 mg and 6 mg Tablets. Anxiolytic - Sedative. Date of Revision: September 6, 2018
PRODUCT MONOGRAPH LECTOPAM bromazepam 3 mg and 6 mg Tablets Anxiolytic - Sedative Hoffmann-La Roche Limited 7070 Mississauga Road Mississauga, Ontario L5N 5M8 Date of Revision: September 6, 2018 www.rochecanada.com
More informationRaritan Bay Medical Center
Raritan Bay Medical Center For any question regarding Med of the Month. You may contact : Sherr Ann Arabit MSN, RN-BC, CCRN Professional Development Department Ext 4196 1 Professional Development Presents
More informationMEDICATION GUIDE Quetiapine Fumarate Extended-Release Tablets (Kwe-TYE-a-peen FUE-ma-rate)
MEDICATION GUIDE Quetiapine Fumarate Extended-Release Tablets (Kwe-TYE-a-peen FUE-ma-rate) Read this Medication Guide before you start taking quetiapine fumarate extended-release tablets and each time
More informationSummary of the risk management plan (RMP) for Aripiprazole Mylan Pharma (aripiprazole)
EMA/370707/2016 Summary of the risk management plan (RMP) for Aripiprazole Mylan Pharma (aripiprazole) This is a summary of the risk management plan (RMP) for Aripiprazole Mylan Pharma, which details the
More informationEastern Shore MediCann Clinic, LLC
Eastern Shore MediCann Clinic, LLC New Patient Medical History and Intake Form Medical Marijuana Certification Name Date of Birth Social Security Number Gender: Male Female Address: Street: City: State
More informationpatient group direction
CYCLIZINE v01 1/7 CYCLIZINE PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner (Nurse)
More informationBroward Oncology Associates, P.A. PATIENT INFORMATION
NAME: BIRTHDATE: AGE: LOCAL ADDRESS (Street city state zip): HOME TELEPHONE# CELL # SOCIAL SECURITY #: - - SEX MARITAL STATUS WHAT IS YOUR HT? WHAT IS YOUR WT? EMPLOYER WORK# SPOUSE'S NAME SPOUSE'S EMPLOYER
More informationPATIENT MEDICAL HISTORY INTAKE FORM
Northgate Professional Center 1985 Main Street, Suite 209 Springfield, Massachusetts 01103 Tel; 413-455-1081 Fax; 413-391-7489 www.marimedconsults.com PATIENT MEDICAL HISTORY INTAKE FORM Patient Information:
More informationPackage leaflet: Information for the user. Cyclizine Lactate 50 mg/ml Injection
Package leaflet: Information for the user Cyclizine Lactate 50 mg/ml Injection Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationDosing & Administration
Dosing & Administration REAL LIFE. REAL RESULTS. INDICATION INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia. Schizoaffective disorder as monotherapy and as an
More informationPatient/Caregiver Information Brochure For Bipolar I Disorder in Adolescents
Patient/Caregiver Information Brochure For Bipolar I Disorder in Adolescents Date of approval: March 2013 Mercury number: 570HQ13NP00107-01-IE 786203127-001_Patient_Caregiver_IRELAND_v4.indd 1 20/03/2013
More informationNow it s time for... Teva Clozapine. (Clozapine, USP Tablets and Orally Disintegrating Tablets) Patient & Family Guide to Teva Clozapine Therapy
Now it s time for... Teva Clozapine (Clozapine, USP Tablets and Orally Disintegrating Tablets) Patient & Family Guide to Teva Clozapine Therapy This is a very important time in your life You and your family
More informationMellaril (thioridazine)
Generic name: Thioridazine Available strengths: 10 mg, 25 mg, 50 mg, 100 mg, 200 mg tablets; 30 mg/ml, 100 mg/ml oral concentrate Available in generic: Yes Drug class: First-generation (conventional) antipsychotic
More informationFlorida Hospital Spine Center Patient Intake Form
Florida Hospital Spine Center Patient Intake Form Today s Date Last Name First Name Middle Street Address DOB (Address, City, State, Zip Code) First Contact # Please Circle: Home Cell Other Second Contact
More informationUnityPoint Clinic - Cardiology
UnityPoint Clinic - Cardiology Date Completed: Appointment Date: Name: Age: Birthdate: / / FIRST MIDDLE INITIAL LAST Referred by: Family Dr.: Reason for visit: Describe briefly, include date of onset:
More informationWELCOME TO THE NORTHSHORE UNIVERSITY HEALTHSYSTEM SLEEP CENTERS
WELCOME TO THE NORTHSHORE UNIVERSITY HEALTHSYSTEM SLEEP CENTERS Prior to your office visit, we request that you complete this questionnaire. It asks questions not only about your sleeping habits and behavior
More informationMethotrexate. About This Drug. Possible Side Effects. Warnings and Precautions
Methotrexate About This Drug Methotrexate is used to treat cancer. This drug is given in the vein (IV). Possible Side Effects Soreness of the mouth and throat. You may have red areas, white patches, or
More informationDexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.
Dexamethasone Other Names: Decadron About This Drug Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Possible Side Effects (More Common) Increased
More informationNew Patient Medical History and Intake Form Medical Marijuana ( MMJ ) Certification
Name Social Security Number Address: Street: _ New Patient Medical History and Intake Form Medical Marijuana ( MMJ ) Certification Date of Birth Gender: Male Female City: State Zip Code E-mail: Home Phone:
More informationNorpramin (desipramine)
Generic name: Desipramine Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets Available in generic: Yes Drug class: Tricyclic antidepressant General Information Norpramin (desipramine)
More informationTHIOTHIXENE. THERAPEUTICS Brands Navane see index for additional brand names. Generic? Yes
THIOTHIXENE THERAPEUTICS Brands Navane see index for additional brand names Generic? Yes Class Conventional antipsychotic (neuroleptic, thioxanthene, dopamine 2 antagonist) Commonly Prescribed for (bold
More informationTalking to Patients and Their Families
Talking to Patients and Their Families About Clozapine The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health
More informationVI.2 Elements for a public summary. VI.2.1 Overview of disease epidemiology
VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Incidence and prevalence of target indication Schizophrenia is a mental disorder characterized by a breakdown of thought processes
More informationAntidepressants. Dr Malek Zihlif
Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric
More informationPrior Authorization with Quantity Limit Program Summary
Gocovri (amantadine) Prior Authorization with Quantity Limit Program Summary This prior authorization applies to Commercial, NetResults A series, SourceRx and Health Insurance Marketplace formularies.
More informationPAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only)
PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only) 1. What is the main problem that you are having? (If additional space is required, please use the back of this
More informationOXYSPAS Tablets (Oxybutynin chloride)
Published on: 10 Jul 2014 OXYSPAS Tablets (Oxybutynin chloride) Composition OXYSPAS-2.5 Tablets Each uncoated tablet contains Oxybutynin chloride... 2.5 mg OXYSPAS-5 Tablets Each uncoated tablet contains
More informationBridges Family Wellness PC. New Patient Intake. Bridges Family Wellness Intake Form SE Lake Rd, Suite 102 Milwaukie, OR
New Patient Intake Bridges Family Wellness Intake Form Full Name: * What is your birthdate? MM/DD/YYYY * What is your gender identity? * Home address: * Cell Phone * Other Phone number(s): Emergency Contact
More informationPresenter. Dr. Ronald Lucchino
Adverse Drug Reactions in Adults with Down Syndrome Presenter Dr. Ronald Lucchino rvluc@comcast.net PURPOSE To increase staff awareness that older adults with DD may have higher levels of medication in
More informationAbilify (aripiprazole)
Abilify (aripiprazole) FDA ALERT [04/2005] Abilify is a type of medicine called an atypical antipsychotic. FDA has found that older patients treated with atypical antipsychotics for dementia had a higher
More informationMEDICATION GUIDE. Aripiprazole Tablets (AR-i-PIP-ra-zole)
MEDICATION GUIDE Aripiprazole Tablets (AR-i-PIP-ra-zole) What is the most important information I should know about aripiprazole tablets? (For other side effects, also see What are the possible side effects
More informationNHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Duloxetine. For the Treatment of Pain
NHS Greater Glasgow And Clyde Pain Management Service Information for Adult Patients who are Prescribed Duloxetine For the Treatment of Pain This information is not intended to replace your doctor s advice.
More informationPRODUCT MONOGRAPH. CLOZARIL (Clozapine Tablets) 25 mg and 100 mg
PRODUCT MONOGRAPH Pr CLOZARIL (Clozapine Tablets) 25 mg and 100 mg Antipsychotic Agent HLS Therapeutics Inc. 10 Carlson Court, Suite 410 Etobicoke, Ontario M9W 6L2 Control No.: 205552 CLOZARIL is a registered
More informationOveractive bladder syndrome (OAB)
Service: Urology Overactive bladder syndrome (OAB) Exceptional healthcare, personally delivered What is OAB? An overactive bladder or OAB is where a person regularly gets a sudden and compelling need or
More informationYOUR GUIDE TO ARIPIPRAZOLE Patient/Caregiver Information Brochure
YOUR GUIDE TO ARIPIPRAZOLE Patient/Caregiver Information Brochure Aripiprazole Dr. Reddy's 5, 10, 15 and 30 mg film-coated tablets Aripiprazole Dr. Reddy s 1 mg/ml Oral Solution Introduction Your doctor
More informationHealth History. Tests and Procedures: Test: Date: Location: Provider: Abnormal: Results/Notes: Monthly self breast exam. Last mammogram (female)
Comprehensive Cancer Center A Cancer Center Designated by the National Cancer Institute Please answer the following questions and bring this form to your first appointment at Rutgers Cancer Institute of
More informationPackage leaflet: Information for the user. Nicovel Frukt 4 mg medicated chewing-gum. nicotine
Package leaflet: Information for the user Nicovel Frukt 2 mg medicated chewing-gum Nicovel Frukt 4 mg medicated chewing-gum nicotine Read all of this leaflet carefully before you start using this medicine
More information